Navigation Links
TRPM7 protein key to breast cancer metastasis in animal models
Date:8/7/2012

PHILADELPHIA The protein transient receptor potential melastatin-like 7 (TRPM7) is a critical determinant of breast cancer cell metastasis, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.

"The most important discovery that we report in this paper is that TRPM7 is required for metastasis, at least in a xenograft model of breast cancer metastasis," said Frank van Leeuwen, Ph.D., assistant professor at the Radbound University Medical Center in Nijmegen, the Netherlands. "While this fundamental biological finding will not have an immediate impact on patient care, we believe that it opens the door to a previously under-explored area of cancer therapeutics.

"TRPM7 functions as a cation channel. As such, it is in a class of proteins that is already therapeutically targeted to treat diseases; for example, cation channel blockers are used to treat several heart conditions. Given that cation channels are druggable, our data provide clear rationale for probing whether drugs that target this class of proteins could block metastasis."

Central to tumor metastasis are changes in the capacity of tumor cells to adhere to other cells and tissue at the original tumor site and changes in their ability to migrate. As TRPM7 was known to be involved in regulating cell adhesion and migration, van Leeuwen and his colleagues, including researchers at The Netherlands Cancer Institute in Amsterdam, set out to investigate whether TRMP7 had a role in cancer cell metastasis.

They evaluated whether the level of expression of the TRPM7 gene correlated with breast cancer progression. In primary breast tumors removed at diagnosis from a cohort of 368 women, high levels of expression from the TRPM7 gene were associated with significantly shorter times to both recurrence of disease and occurrence of distant metastases. This association was validated in an independent cohort of 144 breast cancer patients.

"We were able to show that high levels of TRPM7 expression independently predicted poor patient outcome in these two cohorts of women," said van Leeuwen. "Whether this is useful for forecasting patient prognosis awaits further validation. Moreover, it has become increasingly clear that it is not possible to stratify breast cancer patients into prognostically meaningful groups based on the level of expression of a single gene. TRPM7 would, therefore, need to be part of a panel of markers predictive of metastasis."

Having established a clinically relevant link between TRPM7 levels and metastatic disease in breast cancer patients, van Leeuwen and his colleagues examined the underlying molecular mechanisms using in vitro and in vivo assays.

The results indicated that knocking down TRPM7 expression in invasive human breast cancer cells impaired their ability to migrate in vitro and their metastatic potential when transferred into mice. Further analysis pinned down molecular and cellular reasons for these observations.

"Our working hypothesis is that TRPM7 has a key role in the cross-talk that goes on between breast cancer cells and their environment," van Leeuwen said. "Breast cancer cells are very sensitive to environmental cues. We think, but have no formal proof as yet, that TRPM7 channels are sensors that enable breast cancer cells to perceive changes in their environment."


'/>"/>
Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
2. UNC team describes novel inflammatory protein function
3. In Mice, Alzheimers-Linked Protein Shows Promise Against MS
4. Protein-based coating could help rehabilitate long-term brain function
5. SFU duos protein discovery links to cancer research
6. Protein build-up leads to neurons misfiring
7. Strong communication between brain and muscle requires both having the protein LRP4
8. Regulation by proteins outside cancer cells points to potential new drug target
9. Loss of protein SPDEF allows prostate cancer cells to gain foothold at possible sites of metastasis
10. The key (proteins) to self-renewing skin
11. Researchers discover rare leukemia-causing protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... In April, Amerec launched a new website designed ... find the best steam and sauna solutions. , First, the Amerec website has been ... brings all of the site’s features, especially the Steam Builder Tool , to ...
(Date:5/3/2016)... ... , ... For over 23 years, Doctors on Liens has committed ... doctors and therapists treating personal injury patients on a lien basis. With the recent ... Rehabilitation in Santa Monica, Doctors on Liens is continuing that tradition. While the ...
(Date:5/3/2016)... ... ... Registration is now open for the 31st annual AIDS Walk Boston & 5K Run ... the Esplanade. The event regularly draws thousands of participants, making it AIDS Action Committee’s largest ... sanctioned by the USA Track & Field Association. , The AIDS Walk & 5K ...
(Date:5/3/2016)... Monica, California (PRWEB) , ... May 03, 2016 , ... ... surgery practice in late 2014, incorporating the injectable filler into his menu of ... of aesthetic transformation. Now, more than a year later, he’s still improving his approach ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... university, has announced today the launch of its Associates and Bachelor's degrees in ... Emeritus of The Rockefeller University, Dr. Torsten N. Wiesel; Chairman and CEO of ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... -- While nearly three-quarters of Americans (71%) are aware of ... only about half report taking any steps to prevent ... new survey announced today by Hologic (Nasdaq: ... Month, Hologic is raising awareness of this major threat ... Osteoporosis is a disease that causes low ...
(Date:5/2/2016)... The global  ultrasound device ... by 2024, according to a new report published ... the sonography market include expanding applications of the ... periodic ultrasound screenings of the breast for breast ... ) High Intensity Focused Ultrasound (HIFU) ...
(Date:4/29/2016)... 29, 2016 ReportsnReports.com adds ... market research report that provides an overview of ... at various stages, therapeutics assessment by drug target, ... and molecule type, along with latest updates, and ... key players involved in the therapeutic development for ...
Breaking Medicine Technology: